Browse articles from EyeWorld.org related to COVID-19. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
While many ophthalmologists have instituted protocols to help reduce the risk and spread of SARS-CoV-2, Terrence P. O’Brien, MD, has added another adjunctive preventative measure to his regimen: a dilute povidone-iodine drop for his patients and himself after in vitro studies confirmed virucidal effect against SARS-CoV-2.
➤ Study: Music reduces anxiety, hypertensive events in cataract surgery ➤ Phase 2 study results for investigational dry AMD treatment ➤ Phase 3 topline results for wet AMD therapeutic ➤ FDA accepts BLA for faricimab ➤ ASCRS news and events
➤ Survey: 96% of ophthalmologists vaccinated against COVID-19 ➤ Phase 2b/3 results from trial for Demodex blepharitis ➤ Data from ongoing Phase 2a study of therapy for geographic atrophy ➤ First patient enrolled in Phase 2 study of nasal spray for neurotrophic keratopathy ➤ Next ASCRS Journal Club on July 8
Rosa Braga-Mele, MD, Cataract editor, introduces some of the articles in the issue and shares what she is most excited about at the upcoming ASCRS Annual Meeting.
While in recent months mask use has been relaxed somewhat as health guidelines are updated to reflect increased vaccination status and declining case numbers, there are situations where mask wear continues. These have been credited with playing a role in saving lives, but they have been associated with some unintended ocular consequences as well.
Finding and hiring great employees has always required the ability to balance the “mostly science” of recruitment and the “mostly art” of selecting a finalist. Adding in a pandemic has shaken up the process further.
➤ FDA grants De Novo authorization for new intense pulsed light device ➤ Post-approval study requirements fulfilled for clear corneal incision sealant ➤ Interim analysis for acute adenoviral conjunctivitis drug ➤ NDA resubmission for injection to treat macular edema associated with uveitis ➤ FDA approves abbreviated NDA for glaucoma drug ➤ Study: Functional and psychosocial impact of Demodex blepharitis ➤ Next ASCRS Journal Club on May 13
➤ Topline data from a Phase 3 study investigating first-in-class DED drop ➤ Research initiative focuses on new glaucoma treatments ➤ Phase 2 trial for oral treatment of diabetic retinopathy begins ➤ New SLT trial recruiting study sites ➤ ASCRS news and events
➤ FDA accepts NDA for fixed-combination mydriatic agent ➤ NDA accepted by FDA for dry eye nasal spray ➤ NDA submitted for drop to treat presbyopia ➤ Study to assess outcomes of ab interno canaloplasty ➤ Largest study of glaucoma genetics published ➤ Iridex and Topcon enter into strategic agreement ➤ COVID-19 vaccine update ➤ ASCRS Journal Club on March 11
2020 was supposed to be the year ophthalmologists highlighted all of the advances in cataract and refractive surgery and the patients who benefited from advanced technology. Then, in March 2020, the world was turned upside down. Chief Medical Editor Eric Donnenfeld, MD, reflects on this and looks forward.